finance.yahoo.com ·
lucid diagnostics inc q1 2026 211211830
Topic context
This topic has been covered 377250 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedLucid Diagnostics (medical diagnostics) reports test volume beat but declining from prior quarter due to one-time events. Focus on VA revenue channel and Medicare LCD clearance. Cash burn remains high; public offering extends runway. No direct commodity or supply chain impact; company-specific operational update with weak commercial mechanism for broader sectors.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Q1 2026 test volume: 3,177 EsoGuard tests, above 2,500-3,000 target.
- Raised $16.8 million in public offering to extend cash runway into 2027.
- Cash burn $12.1 million in Q1.
- Average allowable amount per adjudicated claim: $1,646.
- Medicare LCD backlog affects 40-50% of addressable patient population.
Related stories
finance.yahoo.com
health tech q1 2026 earnings 215402558
finance.yahoo.com
ncmi q1 2026 earnings transcript 154748256
finance.yahoo.com
transcript valneva q1 2026 earnings 155143868
finance.yahoo.com
aytu aytu q3 2026 earnings 215448614
timesofindia.indiatimes.com